Singular Health Group Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Singular Health Group şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-21.7%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-21.7%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

We're Hopeful That Singular Health Group (ASX:SHG) Will Use Its Cash Wisely

Jan 11

Singular Health Group (ASX:SHG) Is In A Good Position To Deliver On Growth Plans

Sep 15

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: SHG şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: SHG şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Singular Health Group Piyasaya Karşı Temettü Getirisi

SHG temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (SHG)	n/a
Pazarın Alt %25'i (AU)	2.6%
Pazarın En İyi %25'i (AU)	6.0%
Sektör Ortalaması (Healthcare Services)	0.9%
Analist tahmini (SHG) (3 yıla kadar)	n/a

Önemli Temettü: SHG şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, SHG şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: SHG şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: SHG herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Singular Health Group Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Insufficient new directors

Singular Health Group Ltd, Annual General Meeting, Nov 14, 2024

Sylvan Capital Management Pte Ltd agreed to acquire Singular 3DP Pty Ltd from Singular Health Group Ltd (ASX:SHG) for AUD 0.45 million.

Full year 2024 earnings released: AU$0.018 loss per share (vs AU$0.049 loss in FY 2023)

New major risk - Shareholder dilution

Co-Founder exercised options to buy AU$125k worth of stock.

Singular Health Group Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million.

New major risk - Negative shareholders equity

New major risk - Shareholder dilution

Singular Health Group Ltd has completed a Follow-on Equity Offering in the amount of AUD 4.123141 million.

Singular Health Group Ltd has filed a Follow-on Equity Offering in the amount of AUD 4.052742 million.

Singular Health Group Ltd Announces Resignation of Sujana Karthik as Joint Company Secretary

Singular Health Group Limited Appoints Kyla Garic, as Chief Financial Officer

Singular Health Group Limited Announces Appointment of Mr. Denning Chong as Chief Executive Officer

Singular Health Group Limited Announces Appointment of Mr. Denning Chong as Chief Executive Officer

Singular Health Group Ltd, Annual General Meeting, Nov 10, 2023

Singular Health Group Ltd, Annual General Meeting, Nov 10, 2023

Full year 2023 earnings released: AU$0.049 loss per share (vs AU$0.058 loss in FY 2022)

Full year 2023 earnings released: AU$0.042 loss per share (vs AU$0.058 loss in FY 2022)

New minor risk - Financial data availability

Singular Health Group Ltd has completed a Follow-on Equity Offering in the amount of AUD 1.05 million.

Singular Health Group Ltd Appoints Sujana Karthik as Chief Financial Officer

First half 2023 earnings released: AU$0.028 loss per share (vs AU$0.033 loss in 1H 2022)

Singular Health Group Ltd (ASX:SHG) acquired certain 3D printing assets from Global3D Pty Ltd.

Singular Health Group Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.591993 million.

Singular Health Group Ltd Launches Interactive Investor Hub

High number of new and inexperienced directors

Singular Health Group Ltd Announces 3Dicom MD Software Receives 510(k) Clearance from US Food and Drug Administration (FDA)

Singular Health Group Ltd Announces 3Dicom MD Software Receives 510(k) Clearance from US Food and Drug Administration (FDA)

Singular Health Group Ltd, Annual General Meeting, Nov 28, 2022

Full year 2022 earnings released: AU$0.058 loss per share (vs AU$0.06 loss in FY 2021)

Singular Health Group Ltd Submits 510(K) Premarket Notification to the US Food and Drug Administration (FDA) for 3Dicom MDTM

Singular Health Group Ltd announced that it expects to receive AUD 0.8 million in funding from Eryu Pty Ltd, Investment Arm and another investor

High number of new and inexperienced directors

We're Hopeful That Singular Health Group (ASX:SHG) Will Use Its Cash Wisely

Singular Health Group Ltd Awards $99,936 in IMCRC Activate Funding & Update on VisualEyes Project

Full year 2021 earnings released: AU$0.06 loss per share (vs AU$0.057 loss in FY 2020)

Singular Health Group (ASX:SHG) Is In A Good Position To Deliver On Growth Plans

Singular Health Group Ltd Releases the First Publicly Available Version of Its Medical File Transfer Protocol

Singular Health Group Ltd Announces the Release of the Premium Tiers of the 3Dicom Viewer Software, 3Dicom Pro & 3Dicom Surgical

Singular Health Group Ltd Receives Purchase Order of $170,000 for Software Development

Singular Health Group Ltd Announces the Appointment of Howard Digby as Director

Singular Health Group Ltd has completed an IPO in the amount of AUD 6 million.

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin